BioNTech shares soar 8% in premarket as COVID-19 vaccines help revenues smash estimates
May 10, 2021 at 09:00 AM EDT
Shares in BioNTech surged 8% in U.S. premarket trading on Monday, after the German biotech’s first-quarter earnings revealed a windfall of revenue and profit amid the global push to vaccinate against COVID-19.